Effect of Alpha Thalassaemia Trait and Enhanced Gamma Chain Production on Disease Severity in Beta Thalassaemia Major and Intermedia

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 1994 Jan 1

PMID 7509151

Citations 7

Authors

P Gringras

B Wonke

J Old

A Fitches

D Valler

A M Kuan

V Hoffbrand

Affiliations

Soon will be listed here.

Abstract

One hundred and twenty patients with homozygous beta thalassaemia were selected to determine the clinical effects of certain genetic factors which may modify disease severity. Genetic analysis defined specific beta thalassaemia mutations, the alpha thalassaemia genotype, and the presence of an XmnI restriction enzyme site, associated with increased fetal haemoglobin (HbF) production under certain conditions. Genotypic data with globin chain synthesis were related to the age when regular transfusions began and subsequent pubertal development. This study showed that the major determinants of disease severity in beta thalassaemia were the beta thalassaemia mutations, with co-inheritance of alpha thalassaemia trait and coinheritance of a high HbF determinant acting as ameliorating factors. The presence of an alpha thalassaemia deletion significantly reduced initial disease severity, although the effect on pubertal development was less clear. It is concluded that detailed genetic analysis should be performed in all newly diagnosed patients with thalassaemia. This, in conjunction with clinical assessment, will help to predict disease severity and prognosis.

Citing Articles

Therapeutic Relevance of Inducing Autophagy in β-Thalassemia.

Gambari R, Finotti A Cells. 2024; 13(11.

PMID: 38891049 PMC: 11171814. DOI: 10.3390/cells13110918.

The Hsp70 chaperone system: distinct roles in erythrocyte formation and maintenance.

Mathangasinghe Y, Fauvet B, Jane S, Goloubinoff P, Nillegoda N Haematologica. 2021; 106(6):1519-1534.

PMID: 33832207 PMC: 8168490. DOI: 10.3324/haematol.2019.233056.

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in β-Thalassemia.

Patsali P, Papasavva P, Christou S, Sitarou M, Antoniou M, Lederer C Int J Mol Sci. 2020; 21(18).

PMID: 32933098 PMC: 7555009. DOI: 10.3390/ijms21186671.

Cut-Off Values of Hematologic Parameters to Predict the Number of Alpha Genes Deleted in Subjects with Deletional Alpha Thalassemia.

Velasco-Rodriguez D, Blas C, Alonso-Dominguez J, Vega G, Soto C, Garcia-Raso A Int J Mol Sci. 2017; 18(12).

PMID: 29236053 PMC: 5751308. DOI: 10.3390/ijms18122707.

Impact of genotype on endocrinal complications in β-thalassemia patients.

Al-Akhras A, Badr M, El-Safy U, Kohne E, Hassan T, Abdelrahman H Biomed Rep. 2016; 4(6):728-736.

PMID: 27284414 PMC: 4887852. DOI: 10.3892/br.2016.646.

References

De Virgiliis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F . Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr. 1988; 113(4):661-9. DOI: 10.1016/s0022-3476(88)80375-5. View

Thein S, Wainscoat J, Sampietro M, Old J, Cappellini D, Fiorelli G . Association of thalassaemia intermedia with a beta-globin gene haplotype. Br J Haematol. 1987; 65(3):367-73. DOI: 10.1111/j.1365-2141.1987.tb06870.x. View

Stoming T, Kutlar A, Kutlar F, Lanclos K, Howard E, Fei Y . A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia. Blood. 1989; 73(6):1705-11. View

Sutton M, Bouhassira E, Nagel R . Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol. 1989; 32(1):66-9. DOI: 10.1002/ajh.2830320113. View

Varawalla N, Old J, Weatherall D . Rare beta-thalassaemia mutations in Asian indians. Br J Haematol. 1991; 79(4):640-4. DOI: 10.1111/j.1365-2141.1991.tb08094.x. View

Winichagoon P, Thonglairoam V, Fucharoen S, Wilairat P, Fukumaki Y, Wasi P . Severity differences in beta-thalassaemia/haemoglobin E syndromes: implication of genetic factors. Br J Haematol. 1993; 83(4):633-9. DOI: 10.1111/j.1365-2141.1993.tb04702.x. View

Thein S . beta-Thalassaemia. Baillieres Clin Haematol. 1993; 6(1):151-75. DOI: 10.1016/s0950-3536(05)80069-1. View

Tanner J, Whitehouse R, Takaishi M . Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child. 1966; 41(219):454-71. PMC: 2019592. DOI: 10.1136/adc.41.219.454. View

Clegg J, Naughton M, Weatherall D . Separation of the alpha and beta-chains of human hemoglobin. Nature. 1968; 219(5149):69-70. DOI: 10.1038/219069a0. View

10.

Orkin S, Kazazian Jr H, Antonarakis S, Goff S, Boehm C, Sexton J . Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature. 1982; 296(5858):627-31. DOI: 10.1038/296627a0. View

11.

Tamagnini G, Lopes M, Castanheira M, Wainscoat J, Wood W . Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia. Br J Haematol. 1983; 54(2):189-200. DOI: 10.1111/j.1365-2141.1983.tb02087.x. View

12.

Wainscoat J, Old J, Weatherall D, Orkin S . The molecular basis for the clinical diversity of beta thalassaemia in Cypriots. Lancet. 1983; 1(8336):1235-7. DOI: 10.1016/s0140-6736(83)92694-6. View

13.

Thein S, Hoffbrand A . Thalassaemia intermedia: a new molecular basis. Br J Haematol. 1984; 56(2):333-7. DOI: 10.1111/j.1365-2141.1984.tb03960.x. View

14.

Gilman J, HUISMAN T . Two independent genetic factors in the beta-globin gene cluster are associated with high G gamma-levels in the HbF of SS patients. Blood. 1984; 64(2):452-7. View

15.

Rosatelli M, Oggiano L, Battista Leoni G, Tuveri T, Di Tucci A, Scalas M . Thalassemia intermedia resulting from a mild beta-thalassemia mutation. Blood. 1989; 73(2):601-5. View